Skip to content

Youmei Wang

4 papers in the library · 16 citations · publishing 2019-2026

Papers

Sort Most recent Most cited

Exposure to Ketamine and 2-Fluorodeschloroketamine Impairs Mitochondrial Oxidative Phosphorylation in Human Cerebral Organoids: Implications for Neurodevelopmental Toxicity.

Current Neuropharmacology June 30, 2026 Jiaying Wang, Rui Zhang, Yuanyuan Ma et al.

Ketamine and its structural analog, 2-Fluorodeschloroketamine, both potent stimulants, can induce euphoria but also cause neurotoxicity, cognitive decline, and neurodevelopmental deficits in the fetus. However, the molecular mechanisms responsible for these neurodevelopmental abnormalities are not yet fully elucidated, particularly concerning effects that are specific to certain cell types....

DOI: 10.2174/011570159x445463260422181312 (opens in new tab) Full text (opens in new tab) 2-fluorodeschloroketamine Human cerebral organoid Mitochondrial dysfunction Neurodevelopment +1

Relative reinforcing effects of dibutylone, ethylone, and N-ethylpentylone: self-administration and behavioral economics analysis in rats.

Psychopharmacology September 2022 Miaojun Lai, Dan Fu, Zeming Xu et al.

Following the emergence of methylone as one of the most popular synthetic cathinones, this group of novel psychoactive substance with names ending in "-lone," such as dibutylone, ethylone, and N-ethylpentylone, appeared on the recreational drug market. The pharmacological mechanisms of dibutylone, ethylone, and N-ethylpentylone are well understood; however, to date, the reinforcing effects of...

DOI: 10.1007/s00213-022-06173-x (opens in new tab) Full text (opens in new tab) Dibutylone Ethylone Methamphetamine N-ethylpentylone +3

2-Fluorodeschloroketamine has similar abuse potential as ketamine.

Addiction Biology May 1, 2022 Feng Li, Han Du, Bo Wu et al. 16 citations

2-Fluorodeschloroketamine (2-FDCK) as a substitute for ketamine has emerged among drug abusers in recent years. However, 2-FDCK has not been controlled or regulated in many countries, which may be partly related to the lack of evidence on its abuse potential. In this study, we evaluated the abuse potential of 2-FDCK via the tests of the conditioned place preference (CPP), locomotor...

DOI: 10.1111/adb.13171 (opens in new tab) Full text (opens in new tab) 2-fluorodeschloroketamine Conditioned place preference Drug discrimination Drug self-administration +1

25C-NBOMe, a Novel Designer Psychedelic, Induces Neurotoxicity 50 Times More Potent Than Methamphetamine In Vitro.

Neurotoxicity Research May 1, 2019 Peng Xu, Qiyang Qiu, Haijie Li et al.

25C-NBOMe is a designer substituted phenethylamine and a high-potency psychedelic that acts on the 5-HT2A receptor. Although 25C-NBOMe overdoses have been related to several deaths in the USA and Europe, very limited data exists on the in vitro neurotoxicity of 25C-NBOMe. In this study, we found that 25C-NBOMe potently reduced cell viability of SH-SY5Y, PC12, and SN4741 cells, with IC50 values...